Published on:

After product recalls, Johnson & Johnson intends to take “corrective actions”

CNN.com recently reported that Johnson & Johnson, the maker of several over-the-counter drugs, is taking corrective actions at its American plant after almost forty children’s versions of drugs were recalled for quality concerns. Product recalls included Tylenol, Motrin, and Benadryl – all popular over-the-counter options when one’s child is sick. If you’re thinking this is déjà vu, you are not completely off base. This latest product recall is the fourth recall in seven months for this division of Johnson & Johnson.

The division of Johnson & Johnson responsible for these drugs said that it took action in the form of a product recall as a precautionary measure because some of the products could have problems with their ingredients while others could contain tiny particles. The “tiny particles” may be solidified product ingredients or manufacturing residue such as tiny metal parts.

The four product recalls in the past seven months began in November 2009, when the company recalled five lots of its Tylenol Arthritis Pain 100 count due to reports of an unusual moldy odor that led to cases of nausea, pain, vomiting, and diarrhea. The next month, the product recall was expanded to include a different lot of the same pill. Then, in January, an undisclosed number of containers of Tylenol, Motrin, and other over-the-counter drugs were recalled after consumers complained of feeling sick from the unusual odor. Now, the company recalls children’s versions of popular drugs.

To read more about the current product recalls affecting children’s products, click the link.